<DOC>
	<DOCNO>NCT00620230</DOCNO>
	<brief_summary>This study evaluate safety tolerability single multiple dos VAK694 healthy volunteer otherwise healthy volunteer history allergy .</brief_summary>
	<brief_title>Safety Tolerability Single Multiple Doses VAK694 Healthy Atopic Subjects</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<criteria>History allergic rhinitis ( Part 2 ) Very low high body weight Heavy recent smoker Exposure human monoclonal antibody Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Allergic rhinitis , anti-interleukin 4</keyword>
</DOC>